NASDAQ · IMCC
Healthcare · Drug Manufacturers - Specialty & Generic
$1.90
Down-$0.04 (-2.06%)
Updated Oct 8, 2026, 12:48 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · IMCC
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
IMCC closed at $1.90 after 21 trading sessions, down 4.52% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $1.90 | $1.94 | $1.83 | $1.90 | 111.2K |
| Oct 6, 2026 | $1.92 | $2.0184 | $1.85 | $1.94 | 137.54K |
| Oct 5, 2026 | $2.01 | $2.01 | $1.85 | $1.94 | 109.03K |
| Oct 2, 2026 | $2.10 | $2.19 | $1.9522 | $2.04 | 170.65K |
| Oct 1, 2026 | $2.42 | $2.4297 | $2.12 | $2.17 | 210.57K |
| Sep 30, 2026 | $2.47 | $2.48 | $2.21 | $2.25 | 418.8K |
| Sep 29, 2026 | $2.53 | $2.77 | $2.4395 | $2.45 | 1.76M |
| Sep 28, 2026 | $2.90 | $2.93 | $2.46 | $2.48 | 322.58K |
| Sep 25, 2026 | $3.11 | $3.11 | $2.83 | $2.84 | 608.06K |
| Sep 24, 2026 | $2.95 | $3.24 | $2.91 | $3.18 | 3.95M |
| Sep 23, 2026 | $3.18 | $3.44 | $2.61 | $2.91 | 29.56M |
| Sep 22, 2026 | $4.50 | $5.70 | $3.56 | $4.14 | 25.8M |
| Sep 21, 2026 | $3.18 | $3.38 | $2.83 | $3.085 | 1.47M |
| Sep 18, 2026 | $3.24 | $8.65 | $2.97 | $4.23 | 104.98M |
| Sep 17, 2026 | $1.62 | $1.7683 | $1.62 | $1.74 | 440K |
| Sep 16, 2026 | $1.61 | $1.70 | $1.61 | $1.63 | 23.78K |
| Sep 15, 2026 | $1.66 | $1.67 | $1.55 | $1.63 | 61.87K |
| Sep 14, 2026 | $1.80 | $1.82 | $1.63 | $1.72 | 143.89K |
| Sep 11, 2026 | $1.75 | $1.81 | $1.74 | $1.75 | 27.76K |
| Sep 10, 2026 | $1.96 | $1.97 | $1.7301 | $1.75 | 47.77K |
| Sep 9, 2026 | $2.04 | $2.2099 | $1.89 | $1.99 | 191.89K |
The latest Smart Investors Daily articles mentioning IMCC.
Company
Market Activity
Research & News
IMCC research
Company profile and research snapshot.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Jan 5, 2026
IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), medical cannabis company with operations in Israel and Germany, announced today that Mr. Alon Dayan has been appointed to the Company's board of directors effective December 31, 2025.
Yahoo · Nov 13, 2025
IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the third quarter and nine months ended September 30, 2025. All amounts are reported in Canadian dollars and compared to the quarter and nine months ended September 30, 2024, unless otherwise stated.
prnewswire.com · Nov 13, 2025
TORONTO and GLIL YAM, Israel , Nov. 13, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the third quarter and nine months ended September 30, 2025. All amounts are reported in Canadian dollars and compared to the quarter and nine months ended September 30, 2024, unless otherwise stated.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning IMCC.
No results
No recent SID articles mention IMCC.
